z-logo
Premium
AARS2‐related ovarioleukodystrophy: Clinical and neuroimaging features of three new cases
Author(s) -
Taglia I.,
Di Donato I.,
Bianchi S.,
Cerase A.,
Monti L.,
Marconi R.,
Orrico A.,
Rufa A.,
Federico A.,
Dotti M. T.
Publication year - 2018
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/ane.12954
Subject(s) - leukodystrophy , leukoencephalopathy , corpus callosum , pathology , medicine , white matter , compound heterozygosity , magnetic resonance imaging , mutation , biology , radiology , genetics , gene , disease
Introduction Adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia ( ALSP ), previously known as hereditary diffuse leukoencephalopathy with axonal spheroids ( HDLS ) or pigmentary orthochromatic leukodystrophy ( POLD ), is the most frequent non‐vascular adult‐onset leukoencephalopathy. It is caused by autosomal dominant mutations in CSF 1R gene. Recently, also autosomal recessive mutations in AARS 2 gene were found to be the cause of an adult‐onset leukodystrophy with axonal spheroids. Our aim was to achieve a genetic diagnosis in a cohort of CSF 1R‐ negative patients, performing a sequence analysis of AARS 2 gene. Material and Methods AARS 2 sequencing was performed in 38 CSF 1 R‐negative patients with clinical and magnetic resonance imaging (MRI) findings of adult‐onset leukoencephalopathy. Results Three patients carrying AARS 2 compound heterozygous mutations have been found. All patients were female with ovarian failure and leukoencephalopathy. In 2 patients, MRI findings were consistent with previous reports while the third patient showed focal white matter ( WM ) lesions in the centrum semiovale and the corpus callosum in the absence of extensive involvement and rarefaction of the WM . MRI spectroscopy showed the presence of increased lactate in 2 patients, thus linking AARS 2 ‐related leukoencephalopathy with other mitochondrial leukoencephalopathies with high levels of cerebral lactate. Conclusion We recommend screening for mutations in AARS 2 gene in CSF 1R‐ negative patients, also in the absence of a clear family history and peculiar MRI findings. Our results also suggest that findings of conventional MRI and MR spectroscopy may be useful in prompting the genetic screening.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here